Spyre Therapeutics
SYRE
#4932
Rank
โ‚น119.17 B
Marketcap
โ‚น2,030
Share price
3.16%
Change (1 day)
34.33%
Change (1 year)

Spyre Therapeutics (SYRE) - Cash on Hand

Cash on Hand as of September 2024 : โ‚น35.24 Billion

According to Spyre Therapeutics's latest financial reports the company has โ‚น35.24 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Spyre Therapeutics - Cash on Hand chart (from 2014 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น28.24 B512.67%
2022-12-31โ‚น4.61 B-33.49%
2021-12-31โ‚น6.93 B-35.2%
2020-12-31โ‚น10.69 B108.5%
2019-12-31โ‚น5.13 B-1.52%
2018-12-31โ‚น5.21 B62.23%
2017-12-31โ‚น3.21 B-25.58%
2016-12-31โ‚น4.31 B96.4%
2015-12-31โ‚น2.19 B1225.2%
2014-12-31โ‚น0.16 B-41.62%
2013-12-31โ‚น0.28 B